Enterprise AI Analysis
Global Loss of Metabolic Responsiveness in Obese Mice During Starvation
Authors: Dongzi Li, Keigo Morita, Toshiya Kokaji, Atsushi Hatano, Akiyoshi Hirayama, Tomoyoshi Soga, Yutaka Suzuki, Masaki Matsumoto, Takaho Tsuchiya, Haruka Ozaki, Satoshi Ohno, Hiroshi Inoue, Yuka Inaba, Hideki Maehara, Hikaru Sugimoto, Yifei Pan & Shinya Kuroda
This analysis explores how obesity impairs the body's fundamental metabolic adaptations to starvation, revealing a systemic loss of responsiveness in key regulatory mechanisms across multiple omics layers in leptin-deficient obese mice.
Executive Impact: Key Findings for Metabolic Health
The research highlights a critical breakdown in metabolic adaptation in obese organisms during periods of nutrient deprivation. This systemic dysregulation, characterized by a global loss of dynamic responsiveness and compensatory elevation of static enzyme levels, has significant implications for understanding and addressing obesity-related metabolic diseases.
0
WT Protein Responsiveness
0
Ob/Ob Protein Responsiveness
0
WT Metabolite Responsiveness
0
Ob/Ob Metabolite Responsiveness
The data reveals that while wild-type mice exhibit robust metabolic adaptations at the protein and metabolite levels during starvation, obese mice show a drastic reduction, with protein responsiveness almost entirely lost. Instead, obese mice rely on persistently elevated enzyme levels, indicating a less flexible, compensatory mechanism. This deepens our understanding of metabolic inflexibility in obesity and points to critical targets for therapeutic intervention.
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
Impaired Responsiveness in Obese Skeletal Muscle
The study found that starvation induces 'responsiveness' in wild-type (WT) mice, characterized by dynamic changes in key regulator metabolites like ATP and AMP, and enzyme proteins, leading to global regulation of metabolic pathways. This responsiveness was significantly diminished in leptin-deficient obese (ob/ob) mice. Notably, protein responses were almost entirely lost in ob/ob mice, with only 0.6% of proteins showing responsiveness compared to 9.2% in WT mice (Table 1). This indicates a critical failure in the adaptive mechanisms of obese muscle to nutrient deprivation.
0.6%
Protein Responsiveness in ob/ob Mice
A stark contrast to 9.2% in WT, highlighting severe impairment in adaptive protein regulation during starvation.
Trans-omics Analysis Workflow
Animal Experiment & Tissue Sampling
→
Multi-omics Data Measurement (Metabolome, Transcriptome, Proteome, Phosphoproteome)
→
Identify Starvation-Responsive & Differential Molecules
→
Construct Global & Pathway Trans-omics Networks
→
Analyze Signaling Pathways
→
Derive Systemic Dysregulation Insights
| Omics Layer | WT Responsive (%) | ob/ob Responsive (%) | Difference (pp) | Key Finding |
|---|---|---|---|---|
| Metabolite | 59.3 | 43.4 | 15.9 | Reduced but still present in ob/ob. |
| Enzyme mRNA | 53.3 | 31.9 | 21.4 | Significant reduction in ob/ob. |
| Enzyme Protein | 9.2 | 0.6 | 8.7 | Almost entirely lost in ob/ob. |
| Transporter mRNA | 48.8 | 36.6 | 12.1 | Reduced responsiveness. |
| Transporter Protein | 11.3 | 0 | 11.3 | Completely lost in ob/ob. |
| TF | 3.5 | 2.9 | 0.6 | No significant genotype difference. |
Dysfunctional AMPK Signaling in Obesity
The study revealed a critical disruption in the energy-sensing AMPK pathway in ob/ob mice. In WT mice, starvation led to a WT-specific increase in AMP/ATP ratio and subsequent activation of AMPK (p-AMPK at Thr172). This crucial adaptive response was significantly attenuated or lost in ob/ob mice, even at early fasting stages. This impaired AMPK activation prevents appropriate downstream phosphorylation events in metabolic enzymes, leading to dysregulation of glucose and lipid metabolism, and suggesting an inability to sense and respond effectively to energy stress.
WT-specific
AMP/ATP Ratio Increase & AMPK Activation
A key energy-sensing pathway response observed in WT, but lost in ob/ob mice, hindering metabolic adaptation.
| Signaling Marker | WT Response | ob/ob Response | Implication |
|---|---|---|---|
| AMP/ATP Ratio | WT-specific increase | Lost | Impaired energy sensing. |
| p-AMPK (Thr172) | WT-specific increase (early phase) | Attenuated/Lost | Failure to activate catabolic processes. |
| p-AKT, PDK1, CREB, Raptor (PI3K/AKT/mTOR) | Common decreases | Maintained decreases | Possible impact on protein synthesis/growth. |
| p-HSL (Ser563, Ser565) | Increased/Decreased (WT-specific) | Not responsive | Impaired lipid metabolism activation in ob/ob. |
| p-ACC (Ser79) | Inhibited (WT) | Activated (ob/ob) | Fatty acid biosynthesis inhibition lost in ob/ob. |
| p-GYS (Ser641) | WT-specific increase | Not responsive | Glycogen synthesis inhibition lost in ob/ob. |
| Protein Synthesis Activators (p-eIF4E, p-S6) | Decreased (common) | ob/ob-higher | Impaired inhibition of protein synthesis in ob/ob. |
| Autophagy Regulator ULK1 | WT-higher activating phosphorylation | ob/ob-higher inhibitory phosphorylation | Reduced protein degradation in ob/ob. |
Systemic Impact of Obesity on Metabolic Adaptation
The study's re-analysis of liver data confirmed that the observed metabolic dysregulations in skeletal muscle, including the global loss of responsiveness and the elevation of enzyme proteins, are systemic features of obesity. Both organs showed a failure in activating the AMPK signaling pathway and an impaired ability to switch fuel utilization under starvation. The persistence of elevated enzyme proteins in ob/ob mice, instead of dynamic regulation, suggests a compensatory, yet potentially maladaptive, strategy to maintain metabolic capacity. This systemic inflexibility highlights the widespread impact of obesity on fundamental metabolic adaptations.
Systemic
Metabolic Dysregulation (Muscle & Liver)
Obesity's impact on adaptive responses is not localized but affects core metabolic organs universally.
| Feature | Skeletal Muscle (ob/ob) | Liver (ob/ob) | Conclusion |
|---|---|---|---|
| Global Responsiveness | Severe Loss | Severe Loss | Consistent systemic impairment. |
| Elevated Enzyme Proteins | Predominantly ob/ob-higher | Predominantly ob/ob-higher | Common compensatory strategy. |
| AMP/ATP Ratio Increase | Lost | Reduced | Impaired energy sensing in both. |
| p-AMPK Activation | Lost/Reduced | Reduced | Both organs show AMPK dysfunction. |
| Fuel Utilization Switch | Failure | Failure | Both fail to appropriately switch fuels. |
| Pathway Regulation | Mainly by differences (static) | Mainly by differences (static) | Static adaptation in both. |
Understanding Study Context and Future Research
The study provides profound insights but acknowledges limitations. The TF inference did not include FOXO1 due to data availability, which is a crucial transcriptional regulator. Future work aims to integrate FOXO1 and account for potential misinterpretation of circadian TFs. Furthermore, using leptin-deficient ob/ob mice, while common, may present leptin-specific effects alongside general obesity. Comparative analyses with diet-induced obesity (DIO) models are essential to differentiate these effects and generalize findings to broader forms of obesity. This ongoing research aims for a comprehensive understanding of metabolic adaptation.
Key Considerations for Broader Applicability
The current study, while impactful, highlights several areas for future refinement to broaden the generalizability of its findings to human obesity:
- FOXO1 Integration: The absence of FOXO1 in TF inference due to data limitations may omit insights into its crucial role in metabolic regulation. Future ChIP-Atlas expansions will allow for its inclusion.
- Circadian TFs: Potential misinterpretation of circadian TFs (e.g., Nr1d1) as starvation-responsive due to their 24-hour expression patterns.
- Leptin-Deficient Model: The
ob/obmouse model, while useful, captures leptin-specific effects which might confound general obesity mechanisms. Leptin directly stimulates AMPK, so its absence could contribute to the observed loss of responsiveness. - Comparative Models: Future studies should include diet-induced obesity (DIO) models to disentangle leptin-specific effects from general obesity-driven mechanisms, thereby strengthening the generalizability of conclusions regarding AMPK activation and metabolic dysregulation.
Calculate Your Potential AI-Driven ROI
Estimate the transformative impact of AI on your operational efficiency and cost savings, tailored to your enterprise specifics.
Estimated Annual Savings
Annual Hours Reclaimed
Your AI Implementation Roadmap
A strategic breakdown of how we integrate cutting-edge AI solutions into your enterprise, ensuring a seamless and impactful transition.
01. Discovery & Strategy
In-depth analysis of your current metabolic research processes and business objectives. We identify key areas where AI can drive significant improvements and define a tailored strategy for integration, leveraging insights from studies like the one analyzed.
02. Data Integration & Model Training
Aggregating and preparing your existing multi-omics data (metabolomics, proteomics, transcriptomics) for AI model training. We develop and train custom AI models to identify patterns and predict metabolic responses, building on the methodologies demonstrated in this research.
03. Pilot Program & Validation
Deploying AI solutions in a controlled pilot environment within your R&D or clinical trials. We rigorously test performance, validate findings against experimental results, and refine models for optimal accuracy and utility in predicting complex biological outcomes.
04. Full-Scale Deployment & Optimization
Rolling out the AI solution across your enterprise. We provide continuous monitoring, support, and iterative optimization to ensure sustained high performance and adaptability to new data, driving ongoing innovation in metabolic science.
Ready to Transform Your Metabolic Research?
Leverage advanced AI to uncover deeper insights from your multi-omics data, accelerate drug discovery, and personalize therapeutic strategies. Schedule a consultation with our experts to design an AI roadmap tailored to your enterprise goals.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat